Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanghui Zhu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ISA Transactions|June 22, 2024
Backstepping control based on adaptive neural network and disturbance observer for reconfigurable variable stiffness actuatorYanghui Zhu, Qingcong Wu, Bai Chen, et al.
Chemmedchem|February 22, 2026
Decoding Class III Phosphatidylinositol 3-Kinase (PtdIns3K) Regulation: Mechanistic Insights and Therapeutic OpportunitiesQiao Liu, Jing Ye, Can Chen, et al.
Leukemia Research|March 31, 2012
The venom of the spider Macrothele raveni induces apoptosis in the myelogenous leukemia K562 cell lineZhonghua Liu, Yan Zhao, Jing Li, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapyJing Ye, Jin Zhang, Yanghui Zhu, et al.
Journal of Clinical Medicine|January 8, 2023
Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and ApoptosisYanghui Zhu, Xiaoyu Wang, Zhaoyang Chen, et al.
Chinese Medical Journal|August 25, 2025
Z-DNA-binding protein 1-mediated programmed cell death: Mechanisms and therapeutic implicationsYuwei Huang, Lian Wang, Yanghui Zhu, et al.
European Journal of Medicinal Chemistry|June 28, 2025
Design, synthesis, and biological evaluation of a dual-action agent targeting bromodomain and extraterminal domain and H<sub>2</sub>S release for the treatment of hepatic and pulmonary injuryYanghui Zhu, Lian Wang, Zhaoping Pan, et al.
Materials Today. Bio|October 13, 2025
Cholesterol modified defense peptide as an EMP2-siRNA delivery system for synergistic immunogene therapy against breast cancerXiaoyun Wang, Siliang Chen, Gu He, et al.
Cell Death & Disease|December 21, 2023
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseasesLian Wang, Yanghui Zhu, Lu Zhang, et al.
Signal Transduction and Targeted Therapy|October 9, 2024
The multiple roles of interferon regulatory factor family in health and diseaseLian Wang, Yanghui Zhu, Nan Zhang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ISA Transactions|June 22, 2024
Backstepping control based on adaptive neural network and disturbance observer for reconfigurable variable stiffness actuatorYanghui Zhu, Qingcong Wu, Bai Chen, et al.
Chemmedchem|February 22, 2026
Decoding Class III Phosphatidylinositol 3-Kinase (PtdIns3K) Regulation: Mechanistic Insights and Therapeutic OpportunitiesQiao Liu, Jing Ye, Can Chen, et al.
Leukemia Research|March 31, 2012
The venom of the spider Macrothele raveni induces apoptosis in the myelogenous leukemia K562 cell lineZhonghua Liu, Yan Zhao, Jing Li, et al.
Acta Pharmaceutica Sinica. B|December 4, 2023
Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapyJing Ye, Jin Zhang, Yanghui Zhu, et al.
Journal of Clinical Medicine|January 8, 2023
Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and ApoptosisYanghui Zhu, Xiaoyu Wang, Zhaoyang Chen, et al.
Chinese Medical Journal|August 25, 2025
Z-DNA-binding protein 1-mediated programmed cell death: Mechanisms and therapeutic implicationsYuwei Huang, Lian Wang, Yanghui Zhu, et al.
European Journal of Medicinal Chemistry|June 28, 2025
Design, synthesis, and biological evaluation of a dual-action agent targeting bromodomain and extraterminal domain and H<sub>2</sub>S release for the treatment of hepatic and pulmonary injuryYanghui Zhu, Lian Wang, Zhaoping Pan, et al.
Materials Today. Bio|October 13, 2025
Cholesterol modified defense peptide as an EMP2-siRNA delivery system for synergistic immunogene therapy against breast cancerXiaoyun Wang, Siliang Chen, Gu He, et al.
Cell Death & Disease|December 21, 2023
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseasesLian Wang, Yanghui Zhu, Lu Zhang, et al.
Signal Transduction and Targeted Therapy|October 9, 2024
The multiple roles of interferon regulatory factor family in health and diseaseLian Wang, Yanghui Zhu, Nan Zhang, et al.
Pageof 2